Global and Local Literature Monitoring

Global and local literature monitoring plays a critical role in identifying reportable Individual Case Safety Reports (ICSRs) and detecting emerging safety signals. Biomapas provides comprehensive post-authorisation pharmacovigilance support through scalable global and local literature monitoring solutions tailored to regional regulatory requirements.

We develop robust search strategies and deliver meaningful results, periodic reports, and inspection-ready documentation to support ongoing safety monitoring activities. Our teams support the review and assessment of identified literature articles and provide input relevant for: 

  • Periodic Safety Update Reports (PSURs)  
  • Periodic Benefit-Risk Evaluation Reports (PBRERs)  
  • ICSRs  

Using automated literature monitoring systems alongside experienced multilingual teams, Biomapas supports rapid implementation of local literature monitoring across 120+ countries, including non-indexed and local journals across Europe, EAEU, CIS, MENA, and other international markets. 

Big Enough To Cover  All Your Needs. Small Enough To Care.

Discover the tailored solutions that Biomapas provides to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Regulatory Affairs

Pharmacovigilance

Medical Information

Big Enough To Cover All Your Needs.
Small Enough To Care.

Discover how Biomapas provides all the support to accelerate your clinical trials and optimize your drug development process.

Clinical Research

Reliable support for every phase of your clinical trial, from recruitment to results.

Pharmacovigilance

Flexible safety monitoring to keep your products compliant and trusted.

Regulatory Affairs

Confidently navigate regulatory challenges with expert support.

Medical Information

Clear, accurate medical information 24/7, tailored for global audiences.

Quality Assurance

Export auditors help identify gaps and close them with actionable solutions.